Logo

BGI Genomics, Zentya Partner to Launch PCR Fecal Test for Colorectal Cancer in Slovakia

Mar 29, 2023 | staff reporter

NEW YORK – BGI Genomics said on Wednesday that it has partnered with Slovak genetic screening company Zentya to launch a fecal DNA test for colorectal cancer in Slovakia.

Named ColoTect 1.0, the test is a noninvasive DNA assay that can trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples using multiplex methylation-specific PCR technology, BGI said.

According to BGI, ColoTect 1.0 is CE-marked and already available in more than 20 countries across southern and eastern Europe, including Slovakia, Hungary, Poland, Romania, and Portugal.

Financial and other terms of the deal were not disclosed.

Filed under

PCR
Molecular Diagnostics
Cancer
Colorectal Cancer
Europe
Asia/Oceania
BGI
collaboration
methylation-specific PCR
Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.